Magnetar Financial LLC Takeda Pharmaceutical CO LTD Transaction History

Magnetar Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $651,000 - $1.02 Million	-50,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$16.88 - $20.83 $844,000 - $1.04 Million	50,000 New	50,000 $987,000
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $2.58 Million - $3.19 Million	-155,555 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $2.6 Million - $3.35 Million	155,555 New	155,555 $3.17 Million

318

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $45.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.